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Human Gene 
Symbol 
 (Localization) Potentially Regulated by Potentially Regulates
Cellular and 
 Developmental Roles  Mutant Mouse Phenotype
Role in Cancer/­
Human Disease
FOXA1 (14q21.1) FOXA2, FOXA3, RXRA, PMA, 
MSA, Ie86, INS1, NR0B2, 
DHT, POU5F1, FOXD3, GR, 
PRKACA, LRP5, ER
GCG, TCF1, TFF1, INS1, 
PRDM15, XBP1, PISD, 
COL18A1, NRIP1, ATP5J, 
DSCAM, NDUFV3, SOD1, 
LIN52, PFKFB1
Epithelial cell differentiation; 
branching morphogenesis; 
development of lung, liver, 
prostate, and pancreas.
Severe growth retardation, hypogly-
cemia, electrolyte imbalance. Die 
soon after birth.
Expressed in luminal 
type A breast cancer; 
expressed in human 
prostate carcinomas.
FOXA2 
(20p11.21)
SHH, GLI1, FOXA2, LPS, 
PMA, NR1H4, IL13, RNF111, 
IFT88, NR4A3, DYNC2LI1, 
GATA6, SFTPC, INS1,  
1-alpha, vitamin D3
FOXA1, FOXA2, Pepck, 
ABCB4, ALDOB, TCF1, SHH, 
HNF4A, SLC10A1, INS1, 
WNT7B, PDX1, DLK1, PCK1, 
FOXA3
Epithelial cell differentiation; 
branching morphogenesis; 
development of forebrain, lung, 
liver, prostate, and pancreas. 
Node and notochord missing. 
Foregut morphogenesis defective. 
Embryos die by E10. Conditional b 
cell knockout causes hypoglycemia. 
Expressed in neuro-
endocrine small cell 
carcinomas.
FOXA3 
(19q13.32)
TCF1, FOXA2, TCF2, PMA, 
Ie86, AGN194204, fenofibrate, 
pirinixic acid, CLOCK, NR0B2, 
GR, PRKACA
Pepck, FOXA1, FOXA2, TF, 
TAT, CYP2C8, CYP2C9, 
CYP2C19, CYP3A4, SLC2A2, 
TCF1, NR3C1
Cell glucose homeostasis and 
response to starvation. 
Expression of several liver-specific 
genes is reduced.
FOXB1 (15q22.2) CTNNB1 Development of neural tube, 
mammillary body nerve process.
Variable phenotype with neural tube 
defects, growth retardation, and re-
duced lactation in surviving females.
FOXC1 (6p25.3) ER, valproic acid, trichostatin 
A, LY294002, camptothecin, 
tert-butyl-hydroquinone, 
TGFB1, Erk, EGF, FLNA
LFNG, EFNB2, DLL1, MESP1, 
NOTCH1, HES5, MESP2, 
TCF15, luciferase reporter 
gene, TBX1, glycosamino-
glycan
Germ cell migration; mesenchy-
mal cell differentiation; develop-
ment of kidney, skeleton, brain, 
ureter, heart, lacrimal gland, 
ovarian follicle, and tooth. 
Hydrocephalus, ocular, skeletal, 
renal, and cardiovascular abnor-
malities. Die shortly after birth. 
Abnormalities in anterior segment in 
heterozygotes.
Functions as tumor 
suppressor. Associated 
with Axenfeld-Rieger 
syndrome and glaucoma 
iris hypoplasia.
FOXC2 (16q24.1) LY294002, TNF, CITED2, Ins, 
IKBKG, IGF2, INSR, CHUK, 
NFKBIA, PD98059, wortman-
nin, SHH, ER, PDGF-BB, PMA
FABP4, CEBPA, PRKAR1A, 
PLIN, ADIPOQ, LFNG, UCP1, 
PPARGC1A, EFNB2, DLL1, 
MESP1, PPARA, NOTCH1, 
SLC2A4, HES5
Cell proliferation; development 
of kidney, heart, ureter, and 
skeleton.
Craniofacial and vertebral column 
defects. Most die perinatally or 
before. Lymph node hyperplasia and 
distichiasis in heterozygotes.
Associated with  
aggressive basal-like 
breast cancers and 
Lymphoedema- 
Distichiasis.
FOXD1  
(5q12-q13)
ETS1, TERT, Small/Large 
T-antigen, HRAS, HOXA11, 
HOXD11, SHH, SMO, SMAD6
PGF, EPHB1, FOXJ1, 
CSNK1A1, ZIC2, ISL1, 
PRKAR1A, Nfat
Axon guidance; kidney 
 development. 
Kidney defects. Die within 1 day 
after birth. 
FOXD2 (1p33) SMO PRKAR1A Modulates cAMP sensitivity; 
kidney development. 
40% have kidney hypoplasia and 
hydroureter.
FOXD3 (1p31.3) retinoic acid, IL3, PAX3 FOXA1, FOXA2 Trophectodermal cell differentia-
tion; placental development. 
Epiblast size is reduced and 
 primitive streak does not form. 
FOXD4 (9p24.3)
FOXD5 (2q13)
FOXD6 (9q21.11)
FOXE1 (9q22.33) TSH, TNF, IFNG, forskolin, 
IGF1, TG, A23187, Insulin, 
PMA, CREB1, decitabine, 
DHT
TPO, SLC5A5, thyroid 
hormone
Development of thyroid gland 
and palate.
Cleft palate, partially developed or 
absent thyroid gland. Die within 2 
days after birth.
Associated with thyroid 
agenesis, cleft palate, 
choanal atresia, polyhy-
dramnios, and spiky hair.
FOXE2  
(22q13-qter)
FOXE3 (1p33) BMP7, Fgfr, MAB21L1 CDKN1C, DNASE2B, PROX1, 
PDGFRA
Epithelial cell proliferation; eye 
development. 
Lens, iris, and corneal epithelium are 
connected. Lens size is reduced.
Associated with 
ocular anterior segment 
 anomalies and cataracts.
FOXF1 (16q24.1) BMP4, 5-fluorouracil, FOXM1, 
FGF10, SMO, FGF7, PTCH1, 
NFkB, TNF, etoposide, SHH
VCAM1, ITGA5, HGF, Collagen 
Type IV, PDGFRA
Epithelial cell proliferation; 
 development of colon, gall 
bladder, lung, mesenchyme, and 
smooth muscle.
Defects in mesodermal differen-
tiation, yolk sac vasculogenesis, 
chorioallantoic fusion, and amnion 
expansion. Die around E9. Heterozy-
gotes have alveolarization defects.
Liver metastasis of 
colorectal cancer 
associated with low 
FOXF1 mRNA in stromal 
fibroblasts. 
FOXF2 (6p25.3) IKBKB, IKBKG, CHUK, TITF1, 
NFKBIA, TNF, SMO
WNT5A, Col I, Collagen Type 
IV, CTNNB1
Epithelial cell proliferation; colon 
development.
Cleft palate, abnormal tongue. Mice 
die shortly after birth.
Liver metastasis of 
colorectal cancer 
associated with low 
FOXF2 mRNA in stromal 
fibroblasts. 
FOXG1 (14q12) SH2B1, Insulin, Fsh, NGFB, 
oleic acid, AKT1, glutamic 
acid, INS, IGF1, OTX1, OTX2, 
GBX2, CHRD, NOG, LPS
BCL2L11, CDKN1A, CDKN1B, 
FASLG, CDKN2B, Cdkn2b, 
SERPINE1, FOXH1, SMAD2, 
RB
Neuronal differentiation; cell 
cycle progression; forebrain 
development.
Cerebral hemispheres are reduced in 
size. Die shortly after birth.
Overexpressed in 
 hepatoblastoma.
FOXH1 (8q24.3) SMAD4, FOXG1B, DHT, 
TGFB1, SIM1, ARNT2
AR, Mix.2, FOXA2 Development of axial and 
prechordal mesoderm, definitive 
and visceral endoderm, 
 notochord, and primitive streak.
Variable pattern defects: either axial 
defects, no anterior structures, or no 
structures from embryo proper.
FoxH1 corepresses 
androgen receptor, which 
plays a role in prostate 
cancer.
FOXI1 (5q35.1) SLC26A4, SLC4A9, SLC4A1, 
ATP6V1B1, SLC12A3
Inner ear development. Defects in vestibulum and cochlea. 
Deaf with impared balance. Overt 
acidosis. 50% die perinatally. 
SnapShot:  
Forkhead Transcription Factors I
Geetu Tuteja and Klaus H. Kaestner
Department of Genetics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
1160 Cell 130, September 21, 2007 ©2007 Elsevier Inc. DOI 10.1016/j.cell.2007.09.005 
See online version for legend and references. 
Forkhead Transcription Factors II will appear 
in the October 5 issue of Cell.
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Forkhead transcription factors were first discovered more than 10 years ago in Drosophila and are characterized by a shared 100 amino acid DNA-binding motif, 
termed the “winged helix” or “forkhead” domain. Conserved forkhead domains have been identified in eukaryotic organisms from yeast to humans. The human genome 
contains more than 40 FOX genes. The forkhead transcription factors have been shown to play diverse roles in development, metabolism, immunology, cancer, and 
cell-cycle control.  
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